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ABSTRACT
Guanine-quadruplexes (G4) consist of non-canonical
four-stranded helical arrangements of guanine-rich
nucleic acid sequences. The bulky and thermo-
dynamically stable features of G4 structures have
been shown in many respects to affect normal
nucleic acid metabolism. In vivo conversion of G4
structures to single-stranded nucleic acid requires
specialized proteins with G4 destabilizing/unwind-
ing activity. RHAU is a human DEAH-box RNA
helicase that exhibits G4-RNA binding and resolving
activity. In this study, we employed RIP-chip
analysis to identify en masse RNAs associated
with RHAU in vivo. Approximately 100 RNAs were
found to be associated with RHAU and bioinformat-
ics analysis revealed that the majority contained po-
tential G4-forming sequences. Among the most
abundant RNAs selectively enriched with RHAU,
we identified the human telomerase RNA template
TERC as a true target of RHAU. Remarkably, binding
of RHAU to TERC depended on the presence of a
stable G4 structure in the 50-region of TERC, both
in vivo and in vitro. RHAU was further found to as-
sociate with the telomerase holoenzyme via the
50-region of TERC. Collectively, these results provide
the first evidence that intramolecular G4-RNAs
serve as physiologically relevant targets for RHAU.
Furthermore, our results suggest the existence of
alternatively folded forms of TERC in the fully
assembled telomerase holoenyzme.
INTRODUCTION
DNA and RNA sequences containing tandem repeats of
guanine tracts can form G-quadruplex (G4) structures,
non-canonical and thermodynamically stable four-
stranded helical arrangements (1,2). The building block
of G4 structures is the G-quartet, a square-planar
assembly of four guanines held together by Hoogsteen
hydrogen bonding. G4 structures result from the consecu-
tive stacking of G-quartets and are further stabilized by
alkali metal ions such as Na
+ or K
+ that position along
the helix axis and coordinate the O6 keto oxygens of the
tetrad-forming guanines. G4 scaffolds are extremely poly-
morphic in the relative orientation of strands (parallel,
anti-parallel or mixed conﬁgurations), length, sequence
and conformation of the loops connecting the G-tracts.
In addition, G4 structures in vitro can result from the
assembly of one (intramolecular G4) or multiple (bi- or
tetramolecular-G4) nucleic acid strands.
Biochemical and biophysical studies have shown in vitro
that stable G4 structures can form spontaneously from
G-rich regions of single-stranded nucleic acid under near
physiological conditions. Genome-wide computational
surveys have identiﬁed more than 300000 potential intra-
molecular G4-forming sequences in the human genome
(3,4) and revealed a higher prevalence of these sequences
in functional genomic regions such as telomeres, pro-
moters (5,6), untranslated regions [UTRs (7,8)] and ﬁrst
introns (9). Taken together, these observations suggest that
G4 structures participate in regulating various nucleic acid
processes, such as telomere maintenance or the control of
gene expression. Nevertheless, because of the lack of evi-
dence that such structures really exist in vivo, G4 struc-
tures have often been considered as a structural curiosity
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son to believe that G4 structures are not merely an in vitro
artefact, as several recent ﬁndings concur with their exist-
ence in cells. First, both a G4-speciﬁc dye and antibodies
raised against telomeric G4-DNA speciﬁcally stained telo-
meres in human and ciliate cells, respectively (10–12). In
addition, several potential G4-forming sequences in pro-
moters were shown to form intramolecular G4 structures
in vitro and to affect gene expression in vivo (13,14). A
possible contribution of G4 to regulating promoter activity
was indicated by impairment of the transcriptional activity
of several genes by G4-stabilizing ligands (14) or a single-
chain antibody speciﬁc for intramolecular G4-DNA (15),
in a manner correlating with the occurrence of predicted
G4 structures in the control regions (16).
Like DNA, RNA can also form G4 structures.
Although, to date, G4-RNAs have not attracted as
much attention as their DNA counterparts, the formation
of G4 structures in RNA is emerging as a plausible regu-
latory factor in gene expression. RNA is more prone than
DNA to form G4 structures due to its single-strandedness,
and G4-RNAs have also proved to be more stable than
their cognate G4-DNA under physiological conditions
(17–19). Bioinformatics analyses of human 50-UTR se-
quences revealed potential G4-forming motifs in as
many as 3000 different RNAs (7,20). Moreover, the for-
mation of G4 structures in 50-UTR was shown to impede
translation initiation (7,21–23). Given that potential G4
sequences have been identiﬁed near splicing and poly-
adenylation sites (24–26), G4 formation may also affect
RNA metabolism at several different stages. Furthermore,
formation of parallel G4-RNA structures has also been
reported in vitro for telomeric RNA repeats [TERRA,
(27–29)] and for the human telomerase template RNA
[TERC, (30)], suggesting that G4-RNA formation also
plays a part in regulatory processes at telomeres.
The discovery of proteins that positively or negatively
stabilize such G4 structures is further indirect evidence for
the existence of such structures in vivo. Among the many
proteins from various organisms that bind to G4-DNAs
in vitro (31), several helicases show ATP-dependent
G4-resolving activity (32–36) and have been clearly impli-
cated in the maintenance of genome integrity (37–40).
RHAU (alias DHX36 or G4R1), a member of the
human DEAH-box family of RNA helicases, exhibits
in vitro G4-RNA binding with high afﬁnity for its sub-
strate, and unwinds G4 structures much more efﬁciently
than double-stranded nucleic acid (41,42). Consistent with
these biochemical observations, RHAU was also shown to
bind to mRNAs in vivo (43) and was identiﬁed as the main
source of tetramolecular G4-RNA-resolving activity in
HeLa cell lysates (42).
Although considerable information is available on the
enzymatic activity of RHAU in vitro, almost nothing is
known about its biological function as a G4-binding/
resolving enzyme in vivo. To address this question, we
sought RNAs bound by RHAU in living cells, surmising
that the identiﬁcation of RHAU-bound RNAs and under-
standing the effects of RHAU should provide important
clues to its function in vivo. To this end, we employed
high-throughput gene array technologies to identify and
quantify the co-puriﬁed RNAs on a genome-wide scale.
With this screen, we identiﬁed about 100 RNAs signiﬁcantly
enriched by RHAU. Computational analysis of RNA se-
quences for potential intramolecular G4 structures
revealed the preferential association of RHAU with tran-
scripts bearing G4-forming motifs, suggesting direct tar-
geting of G4-RNA by RHAU. Amongst the RNAs with
the potential to form G4 structures and selectively
enriched with RHAU, we identiﬁed TERC as a bona ﬁde
target of RHAU. Characterization of the RHAU-TERC
interaction in vivo and in vitro showed binding of TERC
by RHAU to be strictly dependent on the formation of a
G4 structure on the 50-extremity of TERC RNA. Finally,
we have demonstrated that RHAU not only interacts with
TERC stricto sensu, but is also part of the fully assembled
telomerase complex through direct interaction with TERC
G4 structure. Taken together, these data demonstrate that
intramolecular G4-RNAs are naturally occurring sub-
strates of RHAU in vivo. Moreover, they provide
indirect but strong support for the existence of a
G4-RNA structure in the telomerase RNP.
MATERIALS AND METHODS
Plasmid constructs, cloning and mutagenesis
The baculoviral expression vector employed for the ex-
pression of GST-RHAU and the plasmids used for the
expression of the C-terminal FLAG-tagged recombinant
RHAU proteins RHAU-FLAG and RHAU(RSM)-
FLAG were previously described (43–45). The pIRES.
EGFP-myc-N1 vector expressing the C-terminal myc-
tagged recombinant RHAU protein was derived from
the previously described pIRES.EGFP-FLAG-N1/
RHAU expression vector (43) by substituting the FLAG
sequence with the myc epitope sequence. Human TERT
cDNA (clone: IOH36343, mapped sequence: NM_198253)
was obtained from ImaGenes GmbH (Berlin, Germany) and
subcloned by PCR ampliﬁcation into the pSL1-FLAG-N1
mammalian expression vector. The pSL1-FLAG-N1 vector
was derived from pEGFP-N1 (Clontech) by replacing the
EGFP open reading frame with the FLAG epitope
sequence. The human TERC genomic region was PCR-
ampliﬁed from the genomic DNA of HEK293T cells to
yield a 2.1-kb fragment encompassing 1080bp of the TERC
promoter, its coding sequence, and 553bp of the 30 ﬂanking
genomic region. This fragment was blunt-cloned into
pGEM-T Easy vector (Promega) at the HincII/EcoRV
sites. The G4 motif sequence of TERC was mutagen-
ized using a variation of the classical QuikChange
(Stratagene) site-directed mutagenesis PCR method (46).
To prepare templates for in vitro run-off transcription, the
T7 or SP6 phage promoters were inserted upstream of the
TERC coding sequence by PCR. The resulting PCR
products were cloned into the pSL1-FLAG-N1 vector at
the NheI/AgeI sites. Following linearization with NarI or
AgeI, in vitro transcription of these templates yielded
the TERC (1–71 nt) and full-length TERC (1–451 nt)
RNA fragments, respectively. Constructions of all these
plasmids were conﬁrmed by sequencing. Sequences of
Nucleic Acids Research, 2011,Vol.39, No. 21 9391oligonucleotides used in this work and detailed descrip-
tions of the plasmid constructs are available upon request.
Cell culture and transfection
Human cervical carcinoma HeLa and embryonic kidney
HEK293T cell lines were maintained in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal
calf serum (FCS) and 2mM L-glutamine at 37 Ci na
humidiﬁed 5% CO2 incubator. Transient transfections
were performed with Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s instructions. Transfected
cells were cultured for 24–36h prior to testing for trans-
gene expression.
RIP-chip assay
Cells were harvested 24–36h post-transfection, washed
with ice-cold PBS and resuspended in lysis buffer
{1  PBS, 1%v·v
 1 Nonidet P-40, 2mM EDTA, 2mM
AEBSF [4-(2-aminoethyl)-benzenesulfonyl ﬂuoride hydro-
chloride], 1  protease inhibitor cocktail (Complete EDTA-
free, Roche), 0.2U·ml
 1 RNasin Plus (Promega)} for
30min. All subsequent operations were performed at
4 C. The lysates were cleared by centrifugation (21000g,
15min) and mixed with 10ml of a 50% slurry of anti-
FLAG M2-agarose afﬁnity gel (Sigma) that had been
equilibrated in lysis buffer. After gentle agitation for 5h,
the resin was recovered by centrifugation, washed 3  with
500ml lysis buffer, followed by three washes with 500ml
IP-washing buffer [50mM Tris–HCl (pH 7.5), 300mM
NaCl, 0.1%v·v
 1Nonidet P-40, 5mM EDTA,
0.4U·ml
 1 RNasin Plus]. The resin was resuspended in
1ml TRIzol (Invitrogen) for protein analysis and RNA
extraction. For microarray analysis, 100ng RNA was con-
verted to cRNA according to the manufacturer’s guide-
lines and the reaction products hybridized to GeneChip
Human Gene 1.0 ST arrays (Affymetrix). The resulting
raw expression values were RMA-normalized using R/
BioConductor (47) and the Oligo Package [version
1.14.0 (48)]. Probesets were linked to Entrez Gene
entries using Affymetrix annotation (NetAffx release 28,
11 March 2009), retaining a single probeset per gene.
Genes not clearly detected in input samples [average
log2(expression value)<6.0] were discarded. Differential
expression was determined using the Limma package
(49), selecting genes with a minimal fold-change of 2.0
and an FDR-adjusted P<0.01. RHAU targets were
identiﬁed as transcripts enriched in RHAU-FLAG IP
versus RHAU-FLAG input samples but not enriched in
control IP versus control RHAU-myc input samples.
G4-RNA structure prediction and bioinformatics analysis
Human RNA sequences were retrieved from Entrez
Nucleotide database. Non-overlapping putative intramo-
lecular G4-forming sequences (PQS) and the correspond-
ing G4-score values were computed with the QGRS
Mapper algorithm (50) using the default parameters
(window size=30 nt, Min. G-group=2, loop size=
0–36). For each transcript, the
P
(G4-score) value was
calculated as the sum of all non-overlapping G4-scores
computed by QGRS Mapper. To obtain a normalized
P
(G4-score) value, the
P
(G4-score) value was divided
by the RNA length (kb). Randomization of RNA se-
quences by single- or dinucleotide shufﬂing was performed
using the Altschul-Erickson algorithm (51).
Protein immunoprecipitation assay
Protein immunoprecipitation experiments were performed
under the same conditions employed for the RIP-chip
assay. Cleared cell lysates were mixed with rProtein A or
Protein G Sepharose
TM Fast Flow beads (GE Healthcare)
and appropriate antibodies {mouse mAb anti-RHAU
[12F33 (43)], rabbit pAb anti-dyskerin (H-300, Santa
Cruz Biotechnology)}. After gentle agitation for 5h, the
beads were washed. For telomere repeat ampliﬁcation
protocol (TRAP) assays, beads were resuspended in
40ml TRAP lysis buffer [10mM Tris–HCl (pH 8.0),
150mM NaCl, 1mM MgCl2, 1mM EDTA (pH 8.0),
1% v·v
 1 Nonidet P-40, 0.25mM Na-deoxycholate,
10% v·v
 1 glycerol, 5mM 2-mercaptoethanol, 0.1mM
AEBSF]. For protein and RNA analysis, beads were re-
suspended in 1ml TRIzol and extraction performed ac-
cording to the manufacturer’s instructions. Input and
co-puriﬁed RNA samples were analysed by RT–qPCR.
For protein analysis only, beads were directly resuspended
in sodium dodecyl sulphate (SDS)-gel loading buffer.
Input and immunoprecipitated protein samples were
separated by SDS–PAGE and analysed by western
blotting.
RNA analysis by quantitative (RT–qPCR) and
semi-quantitative RT–PCR
Reverse transcription was performed using the ImProm-
II
TM Reverse Transcription System (Promega) with
oligo(dT)15 or random hexamer primers, according to
the manufacturer’s instructions. For monitoring ﬁrst-
strand cDNA synthesis, the reverse transcription reaction
was performed in the presence of 20mCi [a-
32P]dATP
(3000Ci·mmol
 1). The reaction products were separated
by agarose gel electrophoresis and visualized by Phosphor-
Imaging. Quantitative and semi-quantitative PCR reactions
were performed in technical duplicates using the
ABsolute
TM QPCR SYBR Green ROX Mix (Thermo
Fisher Scientiﬁc), according to the manufacturer’s instruc-
tions, on an ABI Prism 7000 Sequence Detection System
(SDS) and analysed with the ABI Prism 7000 SDS 1.0
Software (Applied Biosystems). Relative transcript levels
were determined using the 2
 Ct method (52). For each
primer pair (Supplementary Table S1), the efﬁciency of
ampliﬁcation was determined to be equal or superior to
1.8. Control reactions lacking the reverse transcriptase or
template RNA conﬁrmed the speciﬁcity of the ampliﬁca-
tion reactions.
TRAP assays
Immunopuriﬁed ribonucleoprotein (RNP) complexes were
assayed for telomerase activity by the TRAP assay (53).
Four microliters of bead-immobilized RNP complexes in
TRAP lysis buffer were incubated (30min, 25 C) in 50ml
TRAP reaction buffer [20mM Tris–HCl (pH 8.3 at room
temperature), 63mM KCl, 1.5mM MgCl2, 0.2mM dNTP
9392 Nucleic Acids Research, 2011,Vol.39, No. 21mix (50mM each of dATP, dTTP, dGTP and dCTP),
0.05%v·v
 1 Tween-20, 1mM EGTA (pH 8.0), 4ng·ml
 1
Cy5-TS primer, 2ng·ml
 1 ACX primer (Supplementary
Table S1), 1U·ml
 1 RNasin Plus, 0.4mg·ml
 1 BSA,
0.04U·ml
 1 Thermo-Start
TM Taq DNA Polymerase
(Thermo Fisher Scientiﬁc)]. The reaction was followed by
a 15-min incubation step at 95 C, followed by 15–17 cycles
of ampliﬁcation (30s at 95 C, 30s at 52 C, 45s at 72 C).
The reaction products were resolved on a pre-
electrophoresed 10% non-denaturing polyacrylamide gel
(19:1 acrylamide:bis ratio) in 0.5  TBE at 4 C for 90min.
After electrophoresis, gels were ﬁxed [500mM NaCl, 50%
v·v
 1 ethanol, 40mM Na-acetate (pH4.2)] for 30min,
scanned on a Typhoon 9400 Imager (GE Healthcare) and
analysed with ImageQuant TL software (Nonlinear
Dynamics). For immunodepletion experiments of RHAU,
the residual telomerase activity in cell extracts was
quantiﬁed by the quantitative TRAP assay [qTRAP,
(53)]. An aliquot of 250ng protein from immunodepleted
HEK293T cell extracts in TRAP lysis buffer was incu-
bated (30min, 25 C) in 25ml qTRAP reaction buffer
[1 ABsolute
TM QPCR SYBR Green ROX Mix, 1mM
EGTA (pH 8.0), 4ng·ml
 1 TS primer, 4ng·ml
 1 ACX
primer (Supplementary Table S1), 0.2U·ml
 1 RNasin
Plus]. The reaction was followed by a 15-min incubation
step at 95 C, followed by 40 cycles of ampliﬁcation (15s at
95 C, 60s at 60 C) on an ABI Prism 7000 Sequence
Detector. The relative telomerase activity was determined
using a standard curve and linear equation model (53).
Expression and puriﬁcation of recombinant RHAU protein
Recombinant wild-type and ATPase deﬁcient
[RHAU(DAIH)] N-terminal GST-tagged RHAU proteins
were expressed in Sf9 cells according to the supplier’s
instructions (PharMingen) and puriﬁed to homogeneity
as described previously (45). Puriﬁed recombinant GST-
RHAU proteins were stored at  80 C. Purity of protein
preparations was assessed by SDS–PAGE (Supplementary
Figure S1) and protein concentrations determined photo-
metrically at 280nm using the calculated extinction coef-
ﬁcient e=166615M
 1·cm
 1.
In vitro synthesis of
32P-labeled TERC transcripts and
intramolecular G4-RNA preparation
Synthetic radio-labeled wild-type and mutant (G4-MT)
telomerase RNAs were prepared by in vitro transcription
using 50mCi [a-
32P]UTP (3000Ci·mmol
 1) and T7 or SP6
RNA polymerases (Promega), respectively, according to
the manufacturer’s instructions. The transcripts were
puriﬁed by denaturing PAGE, ethanol precipitated and
recovered by centrifugation. The puriﬁed RNAs were re-
suspended in potassium- or lithium-based storage buffer
[10mM Li-cacodylate (pH 7.4), 100mMKCl or LiCl] and
annealed by heating at 95 C for 2min, followed by slow
cooling to room temperature. G4-annealed radio-labeled
RNAs were stored at  80 C.
RNA electromobility shift assay
Puriﬁed recombinant GST-RHAU protein at concentra-
tions from 1 to 320nM was incubated with 100pM
32P-labeled G4-RNA in K-Res buffer [50mM
Tris–acetate (pH 7.8), 100mM KCl, 10mM NaCl, 3mM
MgCl2, 70mM glycine, 10% glycerol], supplemented with
10mM EDTA and 0.2U·ml
 1 SUPERase-In (Ambion) in
a 10-ml reaction. The reactions were equilibrated at 22 C
for 30min. RNA–protein complexes were resolved on a
pre-electrophoresed 6% non-denaturing polyacrylamide
gel (37.5:1 acrylamide:bis ratio) in 0.5  TBE at 4 C for
90min. After electrophoresis, gels were ﬁxed for 1h in
10% isopropanol/7% acetic acid. RNA–protein com-
plexes were detected by Phosphor-Imaging, scanned on a
Typhoon 9400 Imager (GE Healthcare) and analysed with
ImageQuant TL software (Nonlinear Dynamics).
RESULTS
Microarray identiﬁcation of RHAU-associated RNAs
To identify endogenous RNAs associated with RHAU
in vivo on a genome-wide scale, we designed a RIP-chip
assay (RNA immunoprecipitation coupled to microarray
analysis). Subsets of RHAU target RNAs were isolated by
immunoprecipitation (IP) assays under optimized conditions
that preserved RNA–protein complexes. Brieﬂy, HeLa cells
were transfected with a vector expressing FLAG-tagged or
myc-tagged RHAU. Immunoprecipitations of non-cross-
linked whole-cell extracts were carried out using anti-
FLAG antibodies. Anti-FLAG IP from cells expressing
myc-tagged RHAU was employed as an IP control
(IPctrl) to assess non-speciﬁc interactions that may occur
during RIP. Following IP, co-fractionated RNAs were
recovered and puriﬁed by standard phenol–chloroform
extraction and converted to cRNA. Products were subse-
quently hybridized to human oligonucleotide arrays.
Western blot analysis of immunoprecipitated proteins
revealed that RHAU-FLAG, but not RHAU-myc, was
efﬁciently enriched from HeLa cell extracts following
IP with anti-FLAG antibody (Figure 1A, bottom).
Oligo(dT)-primed reverser-transcription of co-immuno-
precipitated RNAs showed the presence of polyadenylated
RNAs with sizes similar to the input (Figure 1A, top,
compare lane 2 to lanes 3 and 4). With regard to the
RHAU-FLAG IP fraction, 10 times less RNA signal
was detected in the control immunoprecipitate (lane1),
demonstrating speciﬁc co-immunoprecipitation of
mRNAs with RHAU. The association between RHAU
and target RNAs was deemed speciﬁc as the anti-FLAG
antibody exhibited no obvious cross-reactivity with other
cellular proteins (data not shown).
Microarray analysis of the puriﬁed RNAs recovered
from input and immunoprecipitated fractions revealed
that 9354 (49%) of the 19089 total genes available on
the chip were signiﬁcantly expressed in HeLa cells
overexpressing RHAU (data not shown). In order to maxi-
mize the chance of identifying true RNA targets of RHAU
as well as to minimize the occurrence of false positives,
only those RNAs were chosen that were signiﬁcantly
(adjusted P<0.01) enriched and were at least 2-fold
more abundant in the RHAU-FLAG IP fraction than in
the control. Of these potential RHAU targets, we dis-
carded those that were also signiﬁcantly enriched in the
Nucleic Acids Research, 2011,Vol.39, No. 21 9393RHAU-myc expressing cells and might thus be RHAU-
independent RNAs binding non-speciﬁcally to the anti-
FLAG antibody matrix.
Thus, of the 9354 genes expressed in HeLa cells, 108
RNAs (1.2%) were found to be signiﬁcantly enriched in
RHAU-FLAG IP fraction compared with total input
RNA (Figure 1B). Finally, after subtraction of two non-
target RNAs based on the above-mentioned criteria that
were associated with the antibody or the beads, 106 RNAs
were judged to be speciﬁcally enriched by RHAU
(Supplementary Table S2). The most abundant transcripts
of these potential RHAU targets were selected for further
analysis.
Validation of potential RHAU target RNAs
To assess independently the validity and reproducibility
of the identiﬁed RHAU-associated transcripts, RNA
abundance in total input RNA, control IP and RHAU-
FLAG IP fractions from fresh whole-cell extracts were
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Figure 1. Analysis of the RNAs co-immunoprecipitated with RHAU RNPs. (A) RHAU associates with poly(A)
+ RNAs in HeLa cells. First strand
cDNA synthesis from input (lanes 3 and 4) and co-immunoprecipitated (lanes 1 and 2) RNAs was monitored by incorporation of [a-
32P]dATP. The
RT–PCR reaction products were separated by agarose gel electrophoresis. An autoradiogram of the gel is shown. The positions and sizes (kb) of
marker DNAs are indicated at the left. Signal intensities are expressed relative to the average signal intensity of the input fractions (lanes 3 and 4).
Expression and speciﬁc enrichment of RHAU-FLAG in input and FLAG-IP fractions were veriﬁed by Western blot analysis. (B) Scatter plot
representation of the differential enrichment of RHAU-bound versus non-speciﬁc RNAs as quantiﬁed by microarray analysis. The pink rectangle
delineates the area of RNA speciﬁcally enriched by RHAU. RNAs whose enrichment was further validated by semi-quantitative RT–PCR are
indicated. (C) Validation of novel RHAU-bound target RNAs. The abundance of 10 potential RHAU targets and four non-targeted RNAs in total
input RNA (lanes 3 and 4), control IP (lane 1) and RHAU-FLAG IP (lane 2) fractions was monitored by semi-quantitative RT–PCR. Reaction
products were separated by agarose gel electrophoresis and visualized by SYBR Green staining. Band intensities are expressed relative to the average
signal intensity of the input fractions (lanes 3 and 4).
9394 Nucleic Acids Research, 2011,Vol.39, No. 21analysed by semi-quantitative RT–PCR. As shown in
Figure 1C, 10 RNAs randomly selected from the group
of plausible RHAU targets were conﬁrmed to be enriched
>2-fold in the RHAU-FLAG IP fraction than in the
control IP or input fractions. Besides, four non-targeted
RNAs were included as negative control to monitor
RHAU binding to non-speciﬁc RNAs. None of them
were found to be enriched in the RHAU-FLAG IP
fraction despite their relatively high abundance in the
input fraction. Taken together, these independents results
validate the previous RIP-chip data. We assume that the
remaining RNA species are also part of RHAU RNPs,
although additional experiments would be necessary to
conﬁrm this supposition.
G4-content analysis for RNAs enriched by RHAU
As RHAU shows a high afﬁnity for G4-RNA structures
in vitro (42), we next carried out a bioinformatics search
for RNAs with potential intramolecular G4 structures.
The rationale was that if RHAU binds G4-RNA in vivo,
the proportion of potential G4-forming sequences should
be higher among RNAs enriched by RHAU than among
non-enriched RNAs. Of the various available methods for
predicting intramolecular G4 motif sequences, we used
QGRS Mapper that identiﬁes and scores each potential
G4-forming sequence according to their predicted stab-
ilities (50). Being aware that only limited experimental
data so far support the scoring method of QGRS
Mapper, we employed the algorithm to identify potential
G4-forming sequences, but we also included the G4-score-
based analysis as Supplementary Data (Supplementary
Figure S2), since the two approaches provided similar
results. In fact, with almost eight potential intramolecular
G4-forming sequences (PQS) per kilobase, the occurrence
of G4 motif sequences was higher in the fraction enriched
by RHAU than in any other fraction (Figure 2A and
Supplementary Figure S2A). In addition, there was a
weak (R
2=0.10) but signiﬁcant positive correlation
between the predicted G4 motif density per transcript
and the magnitude of RNA enrichment by RHAU.
Randomization of RHAU target sequences, retaining
single- or even dinucleotide frequencies of the original
transcripts, signiﬁcantly reduced the proportion of poten-
tial G4-forming sequences (Figure 2B and Supplementary
Figure S2B). Thus, the proportion of G4 motif sequences
among RHAU-associated transcripts cannot be explained
by a mere bias in nucleotide composition.
It should be mentioned that our prediction is likely to
overestimate the number of G4-forming motif sequences
per transcript. In fact, we also considered G4 structures
consisting of only two successive G-tetrads as these meta-
stable structures have also been demonstrated to have
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Figure 2. Computational analysis of potential intramolecular
G4-forming sequences (PQS) among RNAs enriched by RHAU. (A)
Box plot representation of the density of potential intramolecular
G4-forming sequences per transcript (PQS·kb
 1) as a function of
their level of enrichment by RHAU. The lower and upper boundaries
of the boxes indicate the 25th and 75th percentiles, respectively. The
white lines within the boxes mark the median. The width of the boxes is
proportional to the number of transcripts found within a group. The
error bars indicate the 10th and 90th percentiles and the ﬁlled circles
the 5th and 95th percentiles. The grey rectangle refers to the group of
106 RNAs speciﬁcally enriched by RHAU and serves as a control
group for multiple comparison analysis. Statistical signiﬁcance was
determined by Kruskal–Wallis one-way ANOVA on ranks and the
Dunn’s test.
nsP 0.05; *P<0.05; **P<0.01. The correlation
between the two variables was estimated by linear regression analysis
(y=2.56x+5.60, R
2=0.10, P<0.001) and is indicated as a grey line
on the graph. (B) PQS analysis among randomized RHAU target se-
quences. The sequences of the 106 transcripts speciﬁcally enriched by
RHAU were shufﬂed, retaining single- or di-nucleotide base compos-
ition of the original transcripts. The box plot represents the density of
PQS (PQS·kb
 1) among the original (not rand.), di-nucleotide shufﬂed
(di-NT rand.) and single-nucleotide shufﬂed (single-NT rand.) se-
quences. Statistical signiﬁcance was determined by one-way repeated
Figure 2. Continued
measures ANOVA and the Dunnett’s test. (C) Proportions of RNAs
bearing stable PQS as a function of their level of enrichment by
RHAU. The grey rectangle refers to the group of 106 RNAs speciﬁcally
enriched by RHAU. The dashed grey line denotes the proportion of
sequences showing stable PQS in the input fraction. Signiﬁcant
(P<0.001) association between the magnitudes of the two variables
was estimated by the chi-square-test-for-trend.
Nucleic Acids Research, 2011,Vol.39, No. 21 9395biologically relevant roles (54). However, after discarding
these less-stable G4 structures from the analysis, we still
observed a signiﬁcant relationship between the proportion
of sequences bearing potentially stable G4-forming se-
quences (composed of three or more stacked G-quartets)
and the magnitude of RNA enrichment by RHAU
(Figure 2C). Indeed, with more than half of the sequences
presenting potentially stable G4-forming sequences, the
group of 106 RNAs identiﬁed as true RHAU targets pre-
sents one of the highest incidences of potentially stable
G4-forming motifs. In summary, the present data are
consistent with preferential association of RHAU with
transcripts containing potential G4-forming sequences,
suggesting direct recognition of G4-RNA structures by
RHAU. To further test this hypothesis, we selected one
of the identiﬁed RHAU targets and addressed the molecu-
lar basis of its interaction with RHAU.
RHAU associates with TERC through its G4
motif sequence
Within the pool of transcripts enriched by RHAU and
showing a high potential to form stable G4, TERC is
the only RNA reported previously to form a stable and
parallel G4 structure in vitro (Figure 3A) (30). TERC was
C
B A
D
Figure 3. RHAU associates with TERC through its G4-motif sequence. (A) Schematic representation of the secondary structure of human TERC
bearing a parallel G4 structure in the 50-extremity as described by Mergny et al. (30). (B) Nucleotide sequence of the WT and G4 motif mutant
(G4-MT and G4) forms of TERC. Guanine tracts that are predicted to form a stable G4-structure are shown bold. Nucleotide substitutions or
deletions in mutant forms of TERC are marked in red. The P1 helix subdomains as well as the template region are indicated. (C) RNA expression
levels of endogenous and recombinant WT and G4 motif mutant forms of TERC in HEK293T cells. Expression was quantiﬁed by RT–qPCR,
normalized to GAPDH expression and endogenous TERC levels set to 1. Data represent the mean±SEM of three independent experiments.
(D) RT–qPCR analysis of the abundance of WT and G4 motif mutant forms of TERC that co-immunoprecipitated with endogenous RHAU
protein. RNA levels in IP fractions are represented in function of their respective abundance in the input fraction. Immunoprecipitation with mouse
IgGs (mIgG) served as a control to assess non-speciﬁc interactions. In lanes 4, 5 and 6, yellow hatches represent the fraction related to endogenous
TERC signal and violet hatches represent the fraction of TERC RNA that non-speciﬁcally interacts with the antibody matrix or the beads. Data
represent the mean±SEM of ﬁve independent experiments. Comparable efﬁciency of RHAU immunoprecipitation in the various fractions was
veriﬁed by western blot analysis with anti-RHAU antibodies.
9396 Nucleic Acids Research, 2011,Vol.39, No. 21also found to be one of the most abundant RNAs enriched
by RHAU in several independent RIP-chip assays using
various cell lines (Supplementary Table S2 and unpub-
lished data). To address the role of the TERC G4 struc-
ture in its efﬁcient co-immunoprecipitation by RHAU, we
cloned the TERC gene, including its promoter and 30
ﬂanking genomic sequence. The 50 extremity of the TERC
sequence was subsequently mutated (G4-MT) or trun-
cated (G4) to prevent G4 formation (Figure 3B). To
avoid effects on the structurally conserved P1 helix by
the introduced substitutions, guanine residues that are
part of both the predicted G4 structure and the P1a
helix region were left intact. The recombinant forms of
TERC were transiently transfected into HEK293T cells
and the accumulation of stable TERC transcripts was moni-
tored by RT–qPCR (Figure3C). After 24h, HEK293T
cells transiently transfected with the TERC(WT) construct
but not with the vector alone showed a substantial
( 200-fold) increase in TERC abundance relative to en-
dogenous TERC levels. Importantly, mutations of the G4
motif (G4-MT or G4) did not inﬂuence the steady-state
level of exogenous TERC expression in these cells since
recombinant wild-type, G4-MT and G4 forms of TERC
accumulated to comparable levels.
To examine the signiﬁcance of the G4 motif sequence
for co-precipitation of TERC with RHAU, we repeated
the RIP assay using HEK293T cells transiently overex-
pressing the wild-type or G4-MT and G4 mutated
forms of TERC. Immunoprecipitations were carried out
on endogenous RHAU using a monoclonal antibody
against RHAU and TERC RNA abundance was analysed
by RT–qPCR (Figure 3D). As already shown for en-
dogenous TERC, a substantial amount of overexpressed
TERC(WT) was also recovered with endogenous RHAU,
as evidenced by a 25-fold enrichment of TERC transcript
over the mock transfection (Figure 3D, compare lanes 4
and 2). In marked contrast, both G4 motif mutated forms
of TERC were barely co-immunoprecipitated with
RHAU, judged by the 95% reduction in TERC abun-
dance in the corresponding fractions compared with the
WT control (Figure 3D, compare lanes 5 and 6 to lane 4).
The drastic reduction in immunoprecipitation of the
TERC mutants was not due to non-speciﬁc RNA degrad-
ation in these fractions. Indeed, comparable levels of
non-speciﬁcally co-immunoprecipitated GAPDH RNA
were found to contaminate all of these fractions. Taken
together, these results indicate that the intact G4 motif
sequence is a prerequisite for TERC association with
RHAU in vivo.
RHAU binds TERC through a G4 structure in the TERC
50-region
In the absence of Mg·NTPs, RHAU speciﬁcally binds to
tetramolecular G4-RNA structures with high afﬁnity
(42,45). The strict requirement for the G4 motif sequence
for effective recovery of TERC by RHAU in vivo sug-
gested that RHAU may also form a stable complex with
TERC through direct binding of the G4-RNA forming
structure. To address this question in vitro, we performed
RNA electromobility shift assays (REMSA) using puriﬁed
recombinant GST-tagged RHAU protein and in vitro
transcribed radio-labeled full-length (1–451 nt) and 50-end
(1–71 nt) TERC fragments. In the absence of protein, the
32P-labeled probes migrated as a single species in the gel
(Figure 4A and B). Addition of increasing amounts of
RHAU to both full-length and 50-end TERC fragments
resulted in the appearance of a high-afﬁnity (estimated
Kd of 10nM) ribonucleoprotein complex of reduced
mobility. In contrast, the stability of the RHAU-TERC
interaction was strongly impaired ( 20-fold reduction)
when formation of the G4 structure was prevented by
mutation of the G4 motif sequence (G4-MT, Figure 4C).
Similarly, conditions that are unfavourable to G4 stability
(substitution of K
+ for Li
+) impaired the RHAU-TERC
interaction to comparable extent (Figure 4D). Replacing
K
+ by Li
+ was indeed shown to strongly reduce the
thermodynamic stability of the TERC G4 structure (30).
Thus, these results demonstrate a direct and speciﬁc inter-
action between RHAU and TERC dependent on RNA
folding into a stable G4 structure. This is consistent with
the above ﬁnding that RHAU can co-immunoprecipitate
the wild-type but not the G4 motif mutated forms of
TERC. Together these observations argue that a
fraction of TERC RNA forms a G4 structure that can
be further bound by RHAU, in vivo.
RHAU associates with telomerase RNPs by direct
interaction with TERC
In cells, the biogenesis of the telomerase holoenzyme fol-
lows a stepwise RNP assembly. Upon transcription, nas-
cent TERC is ﬁrst bound by proteins dyskerin, NHP2
and NOP10 and subsequently joined by GAR1 (55).
The co-transcriptional binding of this RNP complex is
essential for the processing and accumulation of TERC
transcripts. Finally, the catalytic protein component tel-
omerase reverse transcriptase (TERT) assembles with the
processed telomerase RNPs and forms the active telomer-
ase holoenzyme. To determine whether RHAU was exclu-
sively interacting with TERC during the transcriptional
process or whether it was also part of the telomerase
RNP, we performed co-IP assays and examined whether
endogenous RHAU co-fractionated with endogenous
dyskerin or FLAG-tagged TERT proteins. Immunoblot
analysis showed that RHAU was present in both
dyskerin and TERT immunoprecipitated fractions but
absent in the control IP (Figure 5A and B, compare
lanes 1 and 2). The association of RHAU with compo-
nents of the telomerase holoenzyme proved to be strictly
dependent on the ability of RHAU to bind the 50-end of
TERC, since overexpression of wild-type but not the G4
motif mutated forms of TERC resulted in extensive en-
richment of co-precipitating RHAU protein (Figure 5A
and B, compare lane 2 to lanes 3, 4 and 5). Although
mutations of the TERC G4 motif sequence severely
impinged on the recruitment of RHAU to the telomerase,
they had no apparent repercussions on the steady-state
expression level (Figure 5C) or on the assembly of the
core components of telomerase. Indeed, as shown in
Figure 5D (compare lane 2 to lanes 3, 4 and 5), similar
levels of TERT protein co-fractionated with dyskerin
Nucleic Acids Research, 2011,Vol.39, No. 21 9397following transient overexpression of either wild-type or
G4 motif mutated forms of TERC. These results suggest
that RHAU does not strictly bind TERC in the course of
its biogenesis but that a fraction of RHAU also associates
with the fully assembled telomerase holoenzyme through
direct interaction with the G4 motif sequence of TERC.
RHAU associates with telomerase activity
As RHAU binding to TERC requires a G4 structure, the
ﬁnding that RHAU co-immunoprecipitated with compo-
nents of the telomerase complex suggested the existence of
an alternatively folded form of TERC bearing a G4 struc-
ture in a fraction of telomerase RNP. To address this
further, immunopuriﬁed RHAU RNP complexes were
analysed for telomerase activity by TRAP assay. In all
the subsequent experiments, parallel immunopuriﬁcation
of dyskerin served as a positive control for telomerase
activity (56). In agreement with previous observations,
TRAP assays of antibody-bound complexes conﬁrmed
that substantial telomerase activity was recovered with
RHAU but not with control IgGs (Figure 6A, top).
Coomassie staining demonstrated similar yields of
immunoprecipitated RHAU and dyskerin proteins
(Figure 6A, bottom) and protein identity was subse-
quently veriﬁed by Western blotting (Figure 6B). To
further examine the apparent signiﬁcance of G4 binding
by RHAU for its recruitment to the telomerase holoen-
zyme, we transiently expressed a FLAG-tagged mutant
version of RHAU (RSM, Supplementary Figure S3A)
that was unable to bind to G4 structures (45). Western
blot analysis conﬁrmed that the wild-type and
G4-binding-deﬁcient (RSM) forms of RHAU were ex-
pressed and recovered to similar levels (Supplementary
Figure S3B). Immunopuriﬁed RHAU fractions were
further assayed for telomerase activity and enrichment
of TERC (Supplementary Figure S3C and D). As previ-
ously observed for endogenous RHAU, immunopuriﬁed
FLAG-tagged RHAU(WT) efﬁciently recovered telomer-
ase activity and co-precipitated TERC. In contrast,
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Figure 4. Gel mobility shift assay for TERC G4 binding by RHAU. (A) Radio-labeled full-length (1–451 nt) and (B)5 0-end (1–71 nt) TERC
fragments at a concentration of 100pM were incubated without protein ( ) or with increasing amounts (1, 3.2, 10, 32, 100 and 320nM) of
GST-tagged RHAU in the absence of ATP. The reaction mixtures were analysed by non-denaturing PAGE. An autoradiogram of the gel is
shown. The positions of the free RNA substrate and the protein–RNA complex are indicated on the left. At concentrations up to 320nM, GST
protein alone had no effect on TERC mobility (data not shown). (C) RNA-binding assay with WT and G4 motif mutant (G4-MT) forms of TERC
50-end (1–71nt) fragments. Radio-labeled TERC fragments were incubated without protein ( ) or with increasing amounts (3.2, 10, 32 and 100nM)
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9398 Nucleic Acids Research, 2011,Vol.39, No. 21negligible telomerase activity and TERC signal were
retrieved from the FLAG-tagged RHAU(RSM)
mutant, showing that G4 binding by RHAU is a pre-
requisite for RHAU binding to TERC. Altogether, these
ﬁndings provide persuasive evidence that a fraction of
RHAU associates with a subpopulation of the telomerase
holoenzyme in vivo through direct interaction with the
G4-motif sequence of TERC.
Finally, to determine the proportion of telomerase activ-
ity associated with RHAU, we carried out immuno-
depletion studies of RHAU in HEK293T cell lysates and
subsequently quantiﬁed the residual TERC level and tel-
omerase activity within these fractions (Figure 6C and D).
Depletion with RHAU antibody signiﬁcantly ablated tel-
omerase activity in an aliquot of the supernatant by 25%,
while  70% of the telomerase activity of the input fraction
was lost following depletion of endogenous dyskerin. As
a control, immunodepletion with control mouse IgGs
produced no signiﬁcant reduction in telomerase activity.
Western blot analysis of the supernatants conﬁrmed that
both RHAU and dyskerin proteins were effectively de-
pleted from the corresponding fractions (Figure 6E).
Furthermore, the quantiﬁcation by RT–PCR of RNA
levels in the immunodepleted fractions was consistent with
the above ﬁndings. Indeed, approximately one quarter of
input TERC, but not unrelated RNAs such as b-actin
mRNA, vanished following depletion of endogenous
RHAU. These results not only corroborate the association
of RHAU with telomerase, but also show that the fraction
of telomerase interacting with RHAU accounts for merely
25% of the total telomerase activity. Nevertheless, these
data provide indirect but explicit evidence of the existence
of an alternatively folded TERC structure bearing a G4
scaffold in the fully assembled telomerase holoenzyme.
ATPase-dependent interaction of RHAU with TERC
The fact that only one quarter of telomerase activity is
linked to RHAU may reﬂect a dynamic interaction be-
tween RHAU and TERC. Indeed, most of the DEAH-
box RNA helicases only transiently interact with nucleic
acid, because they do not remain bound after the ATPase-
dependent remodelling of their substrate (57–60). To gain
insight into the role of ATP-hydrolysis by RHAU in its
interaction with TERC, we repeated gel mobility shift
assays with 50 TERC fragments in the presence of Mg
2+
or ATP or both. As shown in Figure 7A, ATP or Mg
2+
alone had little effect on the binding afﬁnity of RHAU for
TERC. In contrast, under conditions supporting ATP hy-
drolysis (Mg·ATP), RHAU displayed reduced binding
afﬁnity for TERC, as evidenced by a 10-fold increase in
the apparent equilibrium Kd value (Figure 7C). Such a
reduction in the afﬁnity of RHAU for TERC was not ob-
served when Mg·ATP was substituted with the non-
hydrolysable ATP analogue Mg·AMP-PNP (Figure 7B
and C). Thus, the present data suggest that intrinsic
RHAU ATP hydrolysis rather than ATP binding is essen-
tial for disrupting the interaction of RHAU with TERC.
To further validate this, we turned to the previously
described RHAU(DAIH) mutant in which the E335A
amino-acid substitution within the Walker B site abolishes
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Figure 5. Association of RHAU with telomerase holoenzyme subunits.
(A) TERC G4 motif dependent association of RHAU with dyskerin.
Proteins from whole HEK293T cell lysates of either mock-transfected
( ) cells or transiently expressing WT or G4 motif mutant (G4-MT,
G4) forms of TERC were immunoprecipitated with either control
mouse IgGs (mIgG) or anti-dyskerin antibodies. Immunopuriﬁed
RNP complexes were separated by SDS–PAGE and probed with
anti-RHAU or anti-dyskerin antibodies. (B) TERC G4 motif-dependent
association of RHAU with TERT. Protein immunoprecipitation experi-
ments with anti-FLAG antibodies were performed with whole cells
lysates of HEK293T cells transiently expressing TERT–FLAG protein
together with WT or G4 motif mutant (G4-MT, G4) forms of TERC.
Immunopuriﬁed RNP complexes were separated by SDS–PAGE and
probed with anti-RHAU or anti-FLAG antibodies. The asterisk
denotes immunoprecipitated TERT–FLAG protein that cross-reacted
unspeciﬁcally with the horsearadish peroxidase-conjugated secondary
antibody. (C) Western blot analysis of comparable protein expression
in input HEK293T cell lysates. (D) Protein immunoprecipitation experi-
ments with anti-dyskerin antibodies were performed with whole cells
lysates of HEK293T cells transiently expressing TERT–FLAG protein
together with WT or G4 motif mutant (G4-MT, G4) forms of TERC.
Immunopuriﬁed RNP complexes were separated by SDS–PAGE and
probed with anti-FLAG or anti-dyskerin antibodies.
Nucleic Acids Research, 2011,Vol.39, No. 21 9399RHAU ATPase activity (45). Unlike wild-type RHAU,
the binding afﬁnity of RHAU(DAIH) mutant for TERC
was similar in the absence and presence of Mg·ATP
(Figure 7B and C). The absence of RHAU helicase
activity as a consequence of the loss of ATPase activity
probably prevents RHAU dissociation from its substrate.
In fact, a similar reduction in in vivo RNA binding
dynamics after suppression of RHAU intrinsic ATPase
activity was reported previously in studies of the shuttling
of RHAU in cytoplasmic stress granules (43). Taken
together, these data corroborate the idea that RHAU is
not permanently associated with TERC but dissociates
upon ATP hydrolysis.
Apart from a high afﬁnity for G4 structures, RHAU
has also been shown to couple ATP hydrolysis with
tetramolecular G4-RNA resolving activity (42,45). These
biochemical properties prompted us to test whether
RHAU could catalyse the conversion of TERC G4 struc-
ture to ssRNA form. However, the faster rate of refolding
of intramolecular G4 structures with regard to
tetramolecular G4-RNAs made it technically difﬁcult to
monitor the G4-resolving activity of RHAU using
standard non-denaturing gel electrophoresis.
DISCUSSION
The propensity of nucleic acid guanine-rich sequences to
self-assemble into G4 structures in vitro has been recogn-
ized for several decades. Although RNA is also prone to
form such structures, G4-RNA has not attracted as much
attention as G4-DNA. Nevertheless, a growing body
of evidence indicates a signiﬁcant role for G4 structure
formation during RNA metabolism (20,61). As a conse-
quence, G4 structures emerged as a plausible post-
transcriptional means of regulating the function of
coding and non-coding RNAs. However, little is known
about the mechanisms by which G4-RNA formation is
regulated in the cells. Indeed, only a few proteins have
been reported so far to interact with G4-RNAs in vitro
(62–66) and, apart from FMRP and FMR2P, experimen-
tal data on their biological activity subsequent to their
interaction with G4-RNAs is scarce. Of these G4-RNA
binding proteins, RHAU is the only protein that exhibits
robust in vitro ATPase-dependent G4-RNA resolving
activity, in addition to a high afﬁnity and speciﬁcity for
its target RNAs (42). These particular biochemical features
promote RHAU as an ideal candidate for regulating G4-
dependent RNA metabolism, although its in vivo RNA
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Figure 6. Association of RHAU with telomerase activity. (A) TRAP assay of immunopuriﬁed endogenous RHAU and dyskerin RNP complexes.
RHAU or dyskerin RNP complexes were enriched by immunoprecipitation and a fraction of the immunopuriﬁed RNP was essayed for telomerase
activity by the TRAP assay. Mouse IgGs (mIgGs) served as a control to assess non-speciﬁc interactions to the antibody matrix. A fraction of the
immunopuriﬁed RNP was separated by SDS–PAGE. The Coomassie stained gel was scanned on a LI-COR Odyssey infrared imaging system.
Positions of the immunoprecipitated proteins as well as the immunoglobulin heavy chains (IgGHC) are indicated at the right. Positions and sizes
(kDa) of marker proteins are shown at the left. (B) Western blot analysis of the immunopuriﬁed RNP complexes assayed for telomerase activity.
(C) qTRAP analysis of the residual telomerase activity present in immunodepleted HEK293T cell lysates. Data represent the mean±SEM of three
independent experiments. Statistical signiﬁcance was determined by one-way ANOVA and the Bonferroni t-test. *P<0.05; **P<0.01; ***P<0.001.
(D) RT–qPCR analysis of the residual levels of TERC and b-actin RNAs in immunodepleted HEK293T cell lysates. The RNA signal was normalized
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Bonferroni t-test. (E) Western blot analysis of input and immunodepleted HEK293T cell lysates. Heat shock protein 70 cognate (HSC70) was used as
a loading control.
9400 Nucleic Acids Research, 2011,Vol.39, No. 21targets have not yet been determined. The present study
aimed to identify naturally occurring RHAU targets with
the emphasis on RNAs containing potential G4-forming
sequences. By RIP-chip assays, 106 RNAs were found to
be signiﬁcantly enriched with RHAU. Importantly, more
than half of these RNAs contained G-rich sequences with
potential to form stable G4 structures. In addition, there
was a weak but signiﬁcant correlation between the pre-
dicted G4 motif density per transcript and the magnitude
of RNA enrichment by RHAU. Nevertheless, because
RHAU appears to show signiﬁcant afﬁnity for RNAs
not bearing G4-forming sequences, we do not exclude
the possibility that RHAU has afﬁnity to other RNA
structural features.
In-depth studies revealed that TERC, one of the identi-
ﬁed RNAs, was a bona ﬁde target of RHAU. Several in-
dependent RIP-chip assays using various cell lines further
showed TERC to be one of the most abundant RNAs
enriched by RHAU. TERC bears a 50 G-rich sequence
that was previously shown to adopt a stable intramolecu-
lar G4 structure in vitro (30). Further investigations dis-
secting the basis of the interaction between RHAU and
TERC showed RHAU binding to be strictly dependent on
G4 structure formation in the 50 region of TERC and to
require the N-terminal RSM domain of RHAU, an ancil-
lary domain necessary for speciﬁc recognition of G4 by
RHAU (45). Moreover, RHAU was found to interact
transiently with TERC in a manner dependent on its
own ATPase activity. Together, these data provide the
ﬁrst evidence of a speciﬁc and direct interaction between
a G4-resolvase enzyme and a potentially relevant intramo-
lecular G4-RNA substrate. Furthermore, in agreement
with our previous reports (42,45), these data attest that
G4-RNAs are naturally occurring substrates of RHAU
in vivo.
The 50 extremity of TERC folds into an intramolecular
G4 structure in vivo
In agreement with the observations presented here,
Mergny and co-workers reported previously the formation
in vitro of a G4 structure in the 50 region of human TERC
(30). However, as for the great majority of nucleic acid
structures, direct experimental demonstration of G4 struc-
tures in vivo has proven very difﬁcult. As such, our results
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Figure 7. Role of Mg·ATP on the interaction of RHAU with TERC. (A) Gel mobility shift assay for TERC G4 binding by RHAU. Radio-labeled
50-end (1–71 nt) TERC fragment at a concentration of 100pM was incubated without protein ( ) or with increasing amounts (3.2, 10, 32 and
100nM) of puriﬁed recombinant GST-tagged RHAU in the presence of 1mM Mg
2+, ATP or Mg·ATP (as indicated). The reaction mixtures were
analysed by non-denaturing PAGE. An autoradiogram of the gel is shown. (B) Gel mobility shift assay of TERC G4 binding by the ATPase deﬁcient
RHAU(DAIH) mutant. Radio-labeled 50-end TERC fragment was incubated without protein ( ) or with increasing amounts (3.2, 10, 32 and
100nM) of puriﬁed recombinant WT or DAIH mutant GST-tagged RHAU in the presence of 1mM Mg
2+,M g ·ATP or Mg·AMP-PNP
(as indicated). (C) Quantiﬁcation of gel mobility shift assays of WT and RHAU(DAIH) mutant binding to TERC 50-end (1–71 nt) fragment.
The data represent the mean of three independent experiments. Error bars for SEM were omitted for clarity.
Nucleic Acids Research, 2011,Vol.39, No. 21 9401do not directly prove the existence of G4 structures in vivo,
but strongly support the notion that TERC can form a G4
structure in the cells. Notably, RHAU can only bind
TERC provided that all conditions necessary for the for-
mation of an intramolecular G4 structure (RNA sequence
and ionic conditions) are met. Modifying any one of
the conditions is sufﬁcient to reduce substantially the
afﬁnity of RHAU for TERC. In addition, our data
argue that TERC G4 structure can also be formed in a
fraction of telomerase holoenzyme, since RHAU associ-
ates with TERT and dyskerin proteins and signiﬁcant
amounts of telomerase activity were recovered with
RHAU. Based on the fraction of telomerase activity
co-precipitating with RHAU, we can estimate that at
least 25% of TERC in the human telomerase holoenzyme
bears a 50 G4 structure. Moreover, we predict that forma-
tion of a G4 structure in TERC is not exclusive to human
cells, since the majority of the mammalian orthologues of
TERC also harbours a potential 50 G4-forming sequence
(Supplementary Figure S4). Insofar as the G4-RNA
binding and resolving activities of RHAU are conserved
in higher eukaryotes (45), it would not be surprising to
ﬁnd that RHAU is part of the telomerase holoenzymes
of other mammals.
As reported previously (30), folding of the 50 region of
TERC into a G4 structure is likely to interfere with the
widely adopted secondary structure of human TERC
(Supplementary Figure S5). Indeed, according to the
standard model of TERC secondary structure (67), two
of the guanine tracts that are part of the intramolecular
G4 also form the P1a helix. As a consequence, the P1a
helix and G4 represent two mutually exclusive structures
and may correspond to different functional states of
TERC. Insofar as helix P1 is required for template
boundary deﬁnition in mammalian telomerase (68), for-
mation of a G4 structure in TERC may be detrimental to
telomerase activity. On the other hand, G4 structure for-
mation may protect TERC from degradation during tel-
omerase biogenesis. Such a scenario was suggested quite
recently by Collins and co-workers, who found that nu-
cleotide substitutions within the G4-forming sequence
markedly reduced accumulation of the mature form of
TERC, thereby causing telomere shortening (69). Similar
to our data, they also found that RHAU associates with
the G4-forming sequence of TERC in vivo, but in contrast
to our ﬁnding, detected negligible telomerase activity with
immunopuriﬁed RHAU fraction. Thus, further experi-
ments are necessary to clarify the functional impact of
G4 formation in TERC on telomerase biogenesis and
activity.
In cells, the P1 duplex- and G4-folded forms of TERC
are likely to coexist in dynamic equilibrium. However,
under physiological conditions, restoration of helix P1
base pairing from the G4-folded conformation of TERC
is likely to require a catalyst due to the high thermo-
dynamic stability of the quadruplex (30). The biochemical
properties and substrate speciﬁcity of RHAU make it a
likely candidate for catalysing such a reaction. Quite apart
from its high afﬁnity for TERC, RHAU manifests robust
tetramolecular G4-RNA resolving activity (42,45) and was
also shown to unwind various intramolecular G4-DNA
structures in vitro (70). These data suggest that RHAU
can resolve G4 structures irrespective of the strand stoi-
chiometry of the G4 stem. Although unwinding of TERC
G4 by RHAU has not yet been demonstrated experimen-
tally, our observation that RHAU dissociates from TERC
upon ATP-hydrolysis, but not upon ATP binding,
supports the idea that RHAU couples ATP-hydrolysis
to conformational changes of TERC, resulting in the reso-
lution of the G4 and further release of RHAU from its
target RNA.
RHAU may target other RNAs containing G4 structures
Apart from TERC, 54 further RNAs found to be
associated with RHAU are predicted to form stable G4
structures (Supplementary Table S2). The determination
of the modalities and the signiﬁcance of these interactions
are essential issues to be addressed in the future.
Nonetheless, the ﬁnding that RHAU associates preferen-
tially with transcripts bearing potential G4-forming se-
quences strongly suggests that RHAU targets G4-RNA
structures in cells. Although nearly three-quarters of
these G4-forming sequences are located in 50 or 30 UTRs
of mRNAs (Supplementary Table S2), it is important to
stress that, to date, we have not observed any suppressive
action of RHAU on translational repression by G4 for-
mation in 50-UTRs. Therefore, RHAU is unlikely to
function as a translational activator but may instead inter-
vene in other aspects of mRNA metabolism, such as pre-
mRNA processing or mRNA turnover. Indeed, RHAU
localizes predominantly in the nucleus, where it concen-
trates in nuclear speckles (71). These are sites of high tran-
scriptional activity and mRNA splicing. Furthermore,
RHAU relocalizes to cytoplasmic stress granules in
response to various cellular stresses (43). Although recruit-
ment of RHAU to stress granules is mediated by inter-
action with RNA, we have not yet examined whether this
phenomenon depends upon binding of RHAU to
G4-RNA structures. However, considering that RSM-
domain mutated forms of RHAU deﬁcient in G4-RNA
binding also show reduced relocalization to stress granules,
it is likely that a fraction of RHAU binds G4 structures in
stress granules.
Together with our previous ﬁndings that RHAU binds
and exhibits robust resolvase activity on various types of
G4 structures (41,42,70), the data presented here bring
forth the idea that G4-RNAs and especially intramolecu-
lar G4-RNAs serve as physiologically relevant targets for
RHAU. Identiﬁcation of naturally occurring substrates of
RNA helicases is a prerequisite to any further investiga-
tion of their biochemical properties in vitro. However,
although most of the RNA helicases achieve highly speciﬁc
tasks in vivo, they often show only little or even no nucleic
acid binding speciﬁcity in vitro. Currently, our major limi-
tation towards understanding the mechanisms, whereby
RNA helicases melt nucleic acid structures stem from
the difﬁculty of identifying such physiologically relevant
substrates. Hence, few detailed molecular models available
for studying RNA helicases in vitro. However, with the
ﬁnding that the 50 region of TERC constitutes a biologic-
ally relevant substrate, RHAU emerges as a novel and
9402 Nucleic Acids Research, 2011,Vol.39, No. 21promising prototype of DEAH-box protein and deserves
more investigations to explore its functions as a G4
resolving enzyme.
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